Emerging Growth Looks at Keryx Biopharmaceutical
Post# of 147
Posted On: 03/08/2013 9:40:42 AM
Emerging Growth Looks at Keryx Biopharmaceuticals
Americans are contracting chronic kidney disease (CKD) by the minute. According to statistics from the National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC), the incidence of CKD is increasing most rapidly in people aged 65 and older. At the end of 2009, more than 871,000 people were being treated for end stage renal disease (ESRD). While health officials make statements about renal problems, companies that specialize in renal diseases are poised to take advantage of the situation..............
(0)
(0)Scroll down for more posts ▼